About Contact Us Careers

Genome Editing Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 4807
Published Date: Oct 09, 2024
Report Format: PDF, PPT

Buy Now

Top Featured Companies Dominating the Global Genome Editing Market

Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Merck KGaA
Horizon Discovery Ltd.
Lonza Group Ltd.
Twist Bioscience Corporation
Akron Biotech.
CRISPR Therapeutics
Sangamo Therapeutics
Editas MedicineIntellia Therapeutics, Inc.

Browse Key Market Insights with Data Illustration:

Genome Editing Market Size & Share, Growth Trends 2037

In the News

Merck acquired AmpTec, a Hamburg-based mRNA contract development and manufacturing organization (CDMO).
Gibco CTS TrueCut Cas9 Protein enables genome editing for research and manufacturing, including CAR T-cell therapy.

Author Credits: Radhika Pawar

Report ID: 4807
Published Date: Oct 09, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of genome editing is evaluated at USD 10.67 billion.

The genome editing market size was valued at USD 9.47 billion in 2024 and is expected to exceed USD 64.48 billion by the end of 2037, registering over 15.9% CAGR during the forecast period i.e., between 2025-2037. Prevalence of cancer worldwide, increased spending on healthcare and rising awareness owing to research will boost the market growth.

North America industry is expected to hold largest revenue share 35% by 2037, due to an increase in population and research activity in the region.

The major players in the market are Merck KGaA, Horizon Discovery Ltd., Lonza Group Ltd.,Twist Bioscience Corporation ,Akron Biotech., CRISPR Therapeutics, Sangamo Therapeutics,Editas Medicine, Intellia Therapeutics, Inc.,Setsuro Tech Inc. and others

Inquiry Before Buying Request Free Sample